logo BDSP

Base documentaire

  1. Cost-effectiveness of the influenza vaccine in a healthy, working-age population.

    Article - En anglais

    To determine if the influenza vaccine can reduce absenteeism and the cost of Influenza-Like Illness (ILI) in healthy adults in the workplace, a prospective, non-randomized, non-placebo control trial was done in six North Carolina textile plants.

    One hundred thirty-one vaccinated employees were compared with 131 age-and gender-matched non-vaccinees from different plants.

    Twenty-six (20%) of the vaccinated and 64 (49%) of the unvaccinated group had ILI (P=0.0000008).

    Fifteen (11%) of the vaccinated and 31 (24%) of the unvaccinated employees missed work because of ILI (P=0.01).

    There were 43 lost workdays in vaccinated and 93 in unvaccinated employees (P=0.00004).

    The « cost per saved lost workday » was $22.36, for a company savings of $2.58 per dollar invested in the vaccination program.

    We concluded that the influenza vaccine can give significant reductions in incidence, absenteeism, and cost associated with ILI in the workplace.

    Mots-clés Pascal : Grippe, Virose, Infection, Vaccination, Programme sanitaire, Prévention, Lieu travail, Impact économique, Absentéisme, Morbidité, Coût, Analyse coût efficacité, Economie santé, Homme, Caroline du Nord, Etats Unis, Amérique du Nord, Amérique

    Mots-clés Pascal anglais : Influenza, Viral disease, Infection, Vaccination, Sanitary program, Prevention, Work place, Economic impact, Absenteeism, Morbidity, Costs, Cost efficiency analysis, Health economy, Human, North Carolina, United States, North America, America

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0340235

    Code Inist : 002B30A03A. Création : 12/09/1997.